The interleukin-4 expression in patients with severe sepsis

Journal of Critical Care

Volumn 23, Issue 4, 2008, Pages 519-524

  Wu, Huang Pin ^a,b   Wu, Chia Ling ^c   Chen, Chian Kuang ^a,b   Chung, Kong ^a,b   Tseng, Jo Chi ^a,b   Liu, Yu Chih ^a,b   Chuang, Duen Yau ^c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Cytokines; Human; Interleukin 4; Interleukin 4 2; Sepsis

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 4; MESSENGER RNA;

AGED; ARTICLE; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL ADMISSION; HUMAN; IMMUNITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; SURVIVAL;

AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; MALE; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEPSIS;

EID: 56949105179     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2007.11.008     Document Type: Article

References (21)

1. Hotchkiss R.S., and Karl I.E. The pathophysiology and treatment of sepsis. N Engl J Med 348 2 (2003) 138-150
2. Reddy R.C., Chen G.H., Tekchandani P.K., et al. Sepsis-induced immunosuppression: from bad to worse. Immunol Res 24 3 (2001) 273-287
3. Fujitsu Y., Fukuda K., Kumagai N., et al. IL-4-induced cell proliferation and production of extracellular matrix proteins in human conjunctival fibroblasts. Exp Eye Res 76 1 (2003) 107-114
4. Atamas S.P., Choi J., Yurovsky V.V., et al. An alternative splice variant of human IL-4, IL-4 delta 2, inhibits IL-4-stimulated T cell proliferation. J Immunol 156 2 (1996) 435-441
5. Arinobu Y., Atamas S.P., Otsuka T., et al. Antagonistic effects of an alternative splice variant of human IL-4, IL-4delta2, on IL-4 activities in human monocytes and B cells. Cell Immunol 191 2 (1999) 161-167
6. Russell J.A. Management of sepsis. N Engl J Med 355 16 (2006) 1699-1713
7. Levy M.M., Fink M.P., Marshall J.C., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31 4 (2003) 1250-1256
8. Knaus W.A., Draper E.A., Wagner D.P., et al. APACHE II: a severity of disease classification system. Crit Care Med 13 10 (1985) 818-829
9. Marshall J.C., Cook D.J., Christou N.V., et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 23 10 (1995) 1638-1652
10. Baumhofer J.M., Beinhauer B.G., Wang J.E., et al. Gene transfer with IL-4 and IL-13 improves survival in lethal endotoxemia in the mouse and ameliorates peritoneal macrophages immune competence. Eur J Immunol 28 2 (1998) 610-615
11. Hess D.J., Henry-Stanley M.J., Erickson E.A., et al. Effect of tumor necrosis factor alpha, interferon gamma, and interleukin-4 on bacteria-enterocyte interactions. J Surg Res 104 2 (2002) 88-94
12. Song G.Y., Chung C.S., Chaudry I.H., et al. IL-4-induced activation of the Stat6 pathway contributes to the suppression of cell-mediated immunity and death in sepsis. Surgery 128 2 (2000) 133-138
13. Hultgren O., Kopf M., and Tarkowski A. Outcome of Staphylococcus aureus-triggered sepsis and arthritis in IL-4-deficient mice depends on the genetic background of the host. Eur J Immunol 29 8 (1999) 2400-2405
14. H1 cytokines and the IL-4 antagonist IL-4delta2. J Immunol 172 11 (2004) 6938-6943
15. Alms W.J., Atamas S.P., Yurovsky V.V., et al. Generation of a variant of human interleukin-4 by alternative splicing. Mol Immunol 33 4-5 (1996) 361-370
16. Seah G.T., Gao P.S., Hopkin J.M., et al. Interleukin-4 and its alternatively spliced variant (IL-4delta2) in patients with atopic asthma. Am J Respir Crit Care Med 164 6 (2001) 1016-1018
17. Glare E.M., Divjak M., Bailey M.J., et al. The usefulness of competitive PCR: airway gene expression of IL-5, IL-4, IL-4delta2, IL-2, and IFNgamma in asthma. Thorax 56 7 (2001) 541-548
18. DiPiro J.T., Howdieshell T.R., Goddard J.K., et al. Association of interleukin-4 plasma levels with traumatic injury and clinical course. Arch Surg 130 11 (1995) 1159-1162
19. Headley A.S., Tolley E., and Meduri G.U. Infections and the inflammatory response in acute respiratory distress syndrome. Chest 111 5 (1997) 1306-1321
20. Hynninen M., Pettila V., Takkunen O., et al. Predictive value of monocyte histocompatibility leukocyte antigen-DR expression and plasma interleukin-4 and -10 levels in critically ill patients with sepsis. Shock 20 1 (2003) 1-4
21. Dheda K., Chang J.S., Huggett J.F., et al. The stability of mRNA encoding IL-4 is increased in pulmonary tuberculosis, while stability of mRNA encoding the antagonistic splice variant, IL-4delta2, is not. Tuberculosis 87 3 (2007) 237-241